Regulatory Approval Marks Milestone in Pakistan’s Pharma Sector The Competition Commission of Pakistan (CCP) has granted Phase-I clearance for the acquisition of Novartis Pharma (Pakistan) Limited by International Investment Limited (IIL). This decision, announced after a thorough competition assessment under Section 11, signals a significant development for the pharmaceutical landscape in Pakistan and the broader…